Pharma Industry
Industry: Email Alert RSS FeedTeva Gets First Fda Approval Of Ketoconazole 2% Cream - Teva Pharmaceutical Industries Ltd - Brief Article - Statistical Data Included
Worldwide Biotech, June, 2000
Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA), Jerusalem, has received from the US Food and Drug Administration an approval to manufacture and market Ketoconazole 2% Cream. Teva USA has launched the product.
Ketoconazole 2% Cream is Teva's generic version of Janssen's anti-fungal drug Nizoral(R) 2% Cream, of which annual US sales are approximately $65 million.
Teva views this approval as significant as it is the first approval for a generic version of this drug. Unlike most oral dosage forms, this product required a 325 patient, 18 center, double-blinded, three-way, placebo controlled clinical study to demonstrate bio-equivalence.
Most RecentPharma Articles
- Sequenom Insider Accused of $366K Stock Sale Before Data Corruption Revealed
- Pfizer Tries Again for Sanctions Against Neurontin Witness
- As Boehringer Develops Viagra for Women, History Suggests High Risk of Failure
- Movie Starring Harrison Ford Tells of Novazyme CEO John Crowley's Quest to...
- FDA Seeks Advice From Blogger; Google Solves Pharma's Ad Problems
- More »
Teva Pharmaceutical Industries Limited is Israel's largest pharmaceutical company, with over 80% of its sales outside Israel mainly in the United States. The company develops, manufactures, and markets generic and branded human pharmaceuticals and active pharmaceutical ingredients.
Corporate Headquarters are at 5 Basel St., P.O. Box 3190, Petah Tiqva 49131, Israel; Tel: 972-3-9267267, Fax: 972-3-9234050.
For more information, call (215)256-8400.
- How to choose the right insurance carrier for your business
- Real Estate: Prepare your properties to weather what lies ahead
- Technology: Be prepared if part of your global supply chain goes missing
Most Recent Technology Articles
- INTERVIEW WITH BEN BUTTERS, DIRECTOR OF EUROPEAN AFFAIRS AT EUROCHAMBRES : "A PERFECT ROAD MAP FOR EU CLUSTERS DOES NOT EXIST".
- AGENDA.(Brief article)(Conference notes)
- FIGHT AGAINST INTERNET PIRACY.
- INTERNET : AUTHORS' SOCIETIES URGE ACTION AGAINST PIRACY.
- TELECOMMUNICATIONS : BUSINESSEUROPE HOSTILE TO FURTHER CONTRACTUAL OBLIGATIONS.(Brief article)
Most Recent Technology Publications
Most Popular Technology Articles
- 3G: naughty or nice? PhoneErotica.com generates over 300 million hits per month, and rings up more minutes of use per month than MSN
- Business process re-engineering in the small firm: A case study
- What is precision air conditioning and why is it necessary?
- Optimizing of Trichoderma viride cultivation in submerged state fermentation
- Performance analysis of shell and tube heat exchanger using miscible system



